| Literature DB >> 19402064 |
Michael B Atkins1, Ronald M Bukowski, Bernard J Escudier, Robert A Figlin, Gary H Hudes, William G Kaelin, W Marston Linehan, David F McDermott, James W Mier, Ivan Pedrosa, Brian I Rini, Sabina Signoretti, Jeffrey A Sosman, Bin Tean Teh, Christopher G Wood, Amado J Zurita, Laura King.
Abstract
The Third Cambridge Conference on Innovations and Challenges in Renal Cancer, a symposium held in Cambridge, Massachusetts, June 27-28, 2008, and chaired by Michael B. Atkins, was convened to discuss the current state of knowledge in the field, critique new data, stimulate communication among those involved in basic and clinical research, and offer recommendations for further study. Four main topics were discussed: genetics and molecular biology of renal cell cancer, staging and prognosis, systemic therapy, and correlative science and biomarkers in stage IV disease. The conference format combined brief presentations with extended periods of discussion. The conclusions and recommendations are summarized in this paper and presented in more detail in the individual papers that follow. (c) 2009 American Cancer Society.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19402064 PMCID: PMC2892290 DOI: 10.1002/cncr.24229
Source DB: PubMed Journal: Cancer ISSN: 0008-543X Impact factor: 6.860